”Exits are not a Strategy. I Never put up a ‘For Sale’ Sign”
23.05.20 | Sophie Shulman and Golan Hazani
This site uses cookies to ensure the best viewing experience for our readers.
UroGen
5 stories about UroGen
Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen
24.04.19 | CTech
Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq
24.01.19 | Lilach Baumer
Sustained Drug Release Company UroGen Submits New Drug Application to FDA
12.07.18 | Amir Rosenbaum
Allergan Partners with Urine Incontinence Treatment Company
08.11.17 | Lilach Baumer
Tag does not exist. Please try again.